Pricing
  1. US-listed companies
  2. IDEXX LABORATORIES INC
  3. Financials
  4. EBITDA

IDEXX LABORATORIES INC (IDXX)

Market cap
$45.8B
P/E ratio
SummaryFinancials
Period EndEBITDA (Million USD)YoY (%)
Dec 31, 20241,258+3.81%
Dec 31, 20231,212+19.92%
Dec 31, 20221,011-2.50%
Dec 31, 20211,037+31.13%
Dec 31, 2020791+23.35%
Dec 31, 2019641+11.55%
Dec 31, 2018575+15.79%
Dec 31, 2017496+15.80%
Dec 31, 2016428+16.15%
Dec 31, 2015369+15.58%
Dec 31, 2014319-0.69%
Dec 31, 2013321+2.03%
Dec 31, 2012315+26.07%
Dec 31, 2010250

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat